Study finds 84% fewer hospitalizations for patients treated with controversial drug hydroxychloroquine
November 25, 2020
A peer-reviewed study measuring the effectiveness of a controversial drug cocktail that includes hydroxychloroquine concluded that the treatment lowered hospitalizations and mortality rates of coronavirus patients.
The study, set to be published in the International Journal of Antimicrobial Agents in December, determined that “Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.”
A total of 141 patients diagnosed with the coronavirus were treated with the three-drug cocktail over a period of five days and compared to a control group of 377 people who tested positive for the virus but were not given the treatment.
The study found that “the odds of hospitalisation of treated patients was 84% less than in the untreated patients,” and only one patient died from the group being treated with the drugs compared to 13 deaths in the untreated group.
Hydroxychloroquine became a controversial issue during the height of the coronavirus pandemic when President Trump championed the drug as an effective coronavirus treatment, which immediately drew criticism from the media and several health experts.
Twitter censored a video over the summer showing doctors touting the effectiveness of the drug.
Additionally, a July study conducted by the Henry Ford Health System in Michigan concluded that patients taking hydroxychloroquine were more likely to survive the coronavirus.